• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Gene expression in myocarditis and dilated cardiomyopathy and basic study of gene therapy by plasmid

Research Project

Project/Area Number 14570645
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionNIIGATA UNIVERSITY

Principal Investigator

HANAWA Haruo  NIIGATA UNIVERSITY, Graduate school of Medical and Dental sciences, Associate Professor, 大学院・医歯学総合研究科, 講師 (40282983)

Co-Investigator(Kenkyū-buntansha) 加藤 公則  新潟大学, 医歯学総合病院, 助手 (00303165)
KODAMA Makoto  NIIGATA UNIVERSITY, Medical and Dental hospital, Assistant, 大学院・医歯学総合研究科, 助教授 (10242447)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥2,200,000 (Direct Cost: ¥2,200,000)
Keywordsmyocarditis / dilated cardiomyopathy / gene expression / angiotensin / cytokine / gene therapy / plasmid / osteopontin
Research Abstract

1)Gene expression in myocarditis and dilated cardiomyopathy
To investigate gene expression in the myocardium of EAM, absolute copy numbers of 44 mRNA species[calcium-handling proteins, contractile proteins, natriuretic peptides(NPs), cytokines, chemokines, growth factors, renin-angiotensin-aldosterone(RAA) system, endothelins(ETs) and extracellular matrix] in synthesized cDNA from a fixed quantity of total heart RNA were assessed using real-time reverse-transcriptase PCR at days 0,14,21 and 28 after immunization. alpha-Cardiac myosin showed a 26.3-fold decrease and beta-cardiac myosin a 3.75-fold increase at day 14. Atrial NP and brain NP increased 47.7-and 6.35-fold at days 21 and 14 respectively. Angiotensin II type I receptor, angiotensin-converting enzyme and ET1 increased 22.3-fold at day 21,6.30-fold at day 21 and 16,8-fold at day 14 respectively. Aldosterone receptor decreased 2.15-fold at day 14,but aldosterohe synthetase was detected only at days 14 and 21. Interleukin(IL)-2,IL … More -10,interferon-gamma and monocyte chemo-attractant protein-1 increased 9.08-fold at day 14,398-fold at day 21,43.1-fold at day 14 and 142-fold at day 14 respectively. Collagen type 3, collagen type 1 and fibronectin increased 34.6-,1.74-and 44.4-fold respectively at day 21. Interestingly, osteopontin showed a 4540-fold increase and it was the highest mRNA of all at day 14. An isofonn of cardiac myosin and NP are dramatically changed in EAM. RAA system and ET expressions are changed differently during the EAM time course. Cytokine, chemokine and extracellular matrix greatly increase and, in particular, large numbers of osteopontin mRNA are expressed in early EAM. After acute inflammation healed, rats were treated with angiotensin converting enzyme inhibitors(ACEI) and type 1 All receptor blockers. These agents had favorable effects on hemodynamics and myocardial contractility, prevented fibrosis, suppressed the expression of ANP, and reversed phenotypic change of cardiac myosin. All receptor blockers were less effective than ACEI.
2)Basic study of gene therapy by naked plasmid
Gene transfer into the liver via rapid tail vein injection can easily be achieved in the rat, which is more than 10 times larger than the mouse, and has significant value for gene function analysis in rats. pCAGGS-vIL-10 gene transfer by hydrodynamics-based transfection suppresses crescentic glomerulonephritis. IFN-gamma, TNF-alpha and MCP-1 to the transcripts of G6PDH in the glomeruli were all significantly lower in the pCAGGS-vIL-10 rats than in the pCAGGS rats. We demonstrated a useful and convenient method to assay gene therapy products circulating in blood using a glucagon 19-29 tagging vector. Less

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Hanawa H: "A Novel Method to Assay Proteins in Blood Plasma after Intravenous Injection of plasmid DNA"Tohoku J Exp Med. 202. 155-161 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tachikawa, H.: "Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis"J Cardiovasc Pharmacol. 41. S105-S110 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fuse K: "Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats"Clin Exp Immunol. 134. 403-408 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Higuchi N: "Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats"Gene Ther. 10. 1297-1310 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Maruyama H: "High-level expression of naked DNA delivered to rat liver via tail vein injection"J Gene Med. 4. 333-341 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hanawa H: "Time course of gene expression in rat experimental autoimmune myocarditis"Clin Sci. 103. 623-632 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hanawa H: "A Novel Method to Assay Proteins in Blood Plasma after Intravenous Injection of plasmid DNA"Tohoku J Exp Med. 202. 155-161 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tachikawa, H: "Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis"J Cardiovasc Pharmacol. 41. S105-S110 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fuse K: "Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats"Clin Exp immunol. 134. 403-408 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Higuchi N: "Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats"Gene Ther. 10. 1297-1310 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Maruyama H: "High-level expression of naked DNA delivered to rat liver via tail vein injection"J Gene Med. 4. 333-341 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hanawa H: "Time course of gene expression in rat experimental autoimmune myocarditis"Clin Sci. 103. 623-632 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hanawa, H.: "A Novel Method to Assay Proteins in Blood Plasma after Intravenous Injection of plasmid DNA"Tohoku J Exp Med. 202(in press). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Kodama, M.: "Effects of humoral factors on left ventricular remodeling under chronic heart failure"Nippon Yakurigaku Zasshi. 123. 63-70 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Tachikawa, H.: "Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis"J Cardiovasc Pharmacol. 41. S105-S110 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Kashimura, T.: "Effects of imidapril and TA-606 on rat dilated cardiomyopathy after myocarditis"Jpn Heart J. 44. 735-744 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Maruyama, S.: "FR167653 suppresses the progression of experimental autoimmune myocarditis"Mol Cell Biochem. 246. 39-44 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Higuchi, N.: "Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats"Gene Ther. 10. 1297-1310 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hanawa H: "Time course of gene expression in rat experimental autoimmune myocarditis"Clin Sci. 103. 623-632 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Maruyama H: "High-level expression of naked DNA delivered to rat liver via tail vein injection"J Gene Med. 4. 333-341 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi